Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomarin Pharmaceuticals
(NQ:
BMRN
)
92.57
-1.27 (-1.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biomarin Pharmaceuticals
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
November 24, 2021
If history is any guide, there may be good fortune ahead for shares of Biomarin Pharmaceutical (NASDAQ:BMRN). A so-called "golden cross" has formed on its chart and, not...
Via
Benzinga
BIOMARIN DEADLINE ALERT
November 23, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses to Contact the Firm
November 23, 2021
From
The Schall Law Firm
Via
Business Wire
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HEPS, BMRN and CTXS
November 22, 2021
NEW YORK, NY / ACCESSWIRE / November 22, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded...
From
The Gross Law Firm
Via
AccessWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses to Contact the Firm
November 22, 2021
From
The Schall Law Firm
Via
Business Wire
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
November 22, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DNA, BMRN and SNAP
November 22, 2021
NEW YORK, NY / ACCESSWIRE / November 22, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Exposures
Legal
Where Biomarin Pharmaceutical Stands With Analysts
November 22, 2021
Over the past 3 months, 6 analysts have published their opinion on Biomarin Pharmaceutical (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Monday
November 22, 2021
MKM Partners cut Activision Blizzard, Inc. (NASDAQ:A...
Via
Benzinga
BIOMARIN SHAREHOLDER ALERT
November 21, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
November 22, 2021
Upgrades According to Evercore ISI Group, the prior rating for Kimco Realty Corp (NYSE:
Via
Benzinga
CLASS ACTION UPDATE for INNV, BMRN and HMLP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
November 20, 2021
NEW YORK, NY / ACCESSWIRE / November 20, 2021 /Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
LAWSUITS FILED AGAINST BMRN, LSPD and SNAP - Jakubowitz Law Pursues Shareholders Claims
November 20, 2021
NEW YORK, NY / ACCESSWIRE / November 20, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...
From
Jakubowitz Law
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
November 20, 2021
The rare-disease specialist might now have a true franchise-level drug following the approval of Voxzogo.
Via
The Motley Fool
Exposures
Product Safety
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
November 19, 2021
Los Angeles, CA - (NewMediaWire) - November 19, 2021 - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BioMarin Pharmaceutical...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BMRN, CEI and Z
November 19, 2021
NEW YORK, NY / ACCESSWIRE / November 19, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Exposures
Legal
BioMarin Stock Jumps As FDA Approval Unlocks Its 'Next Growth Inflection'
November 19, 2021
The BioMarin drug treats achondroplasia, a form of short-limbed dwarfism.
Via
Investor's Business Daily
Exposures
Product Safety
FDA Conditionally Approves Biomarin's Dwarfism Drug
November 19, 2021
The FDA has approved BioMarin Pharmaceutical Inc's (NASDAQ: BMRN) Voxzogo (vosoritide) for Injection for achondroplasia. The approval comes for achondroplasia...
Via
Benzinga
Exposures
Product Safety
CLASS ACTION UPDATE for BMRN, AMRN and Z: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
November 19, 2021
NEW YORK, NY / ACCESSWIRE / November 19, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
BIOMARIN DEADLINE ALERT
November 19, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
November 18, 2021
LOS ANGELES, CA - (NewMediaWire) - November 18, 2021 - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BioMarin Pharmaceutical...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HEPS, BMRN and HMLP
November 18, 2021
NEW YORK, NY / ACCESSWIRE / November 18, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
COVID-19
Financial
Legal
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Novartis AG (NYSE: NVS) is getting a massive influx of cash from selling its 20-year stake in Roche Holdings AG (OTC: RHHBY), triggering speculation...
Via
Benzinga
NASDAQ:BMRN Investor Notice: Lawsuit Alleges Misleading Statements by BioMarin Pharmaceutical Inc.
November 18, 2021
San Diego, CA -- (SBWIRE) -- 11/18/2021 -- An investor, who purchased NASDAQ:BMRN shares, filed a lawsuit against BioMarin Pharmaceutical Inc. over alleged violations of Federal Securities Laws.
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
BIOMARIN SHAREHOLDER ALERT
November 17, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
LAWSUITS FILED AGAINST BMRN, Z and LSPD - Jakubowitz Law Pursues Shareholders Claims
November 17, 2021
NEW YORK, NY / ACCESSWIRE / November 17, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...
From
Jakubowitz Law
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
November 17, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BMRN, TMC and SBTX
November 17, 2021
NEW YORK, NY / ACCESSWIRE / November 17, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded...
From
The Gross Law Firm
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
November 16, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BMRN, RECAF and ONTF
November 16, 2021
NEW YORK, NY / ACCESSWIRE / November 16, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded...
From
The Gross Law Firm
Via
AccessWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.